Technical Analysis for HRTX - Heron Therapeutics, Inc.
| Grade | Last Price | % Change | Price Change |
|---|---|---|---|
 |
18.43 | -1.71% | -0.32 |
HRTX closed down 1.71 percent on Thursday, June 4, 2020, on 84 percent of normal volume. Its advance stalled at its 200 day moving average, an important long-term support / resistance line. The price action carved out a bearish shooting star candlestick pattern. That may indicate a downside reversal. Look for price to trade beneath the low of the shooting star for confirmation. Due to the stock's strong uptrend, it may remain overbought for a while. So, if you're looking for a reason to sell, don't put too much weight on it being overbought.
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Strong | Down | Up | Flat |
| Historical HRTX trend table... | |||
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| 200 DMA Resistance | Bearish | 0.00% | |
| Shooting Star Candlestick | Bearish | 0.00% | |
| Outside Day | Range Expansion | 0.00% | |
| Wide Bands | Range Expansion | 0.00% | |
| Overbought Stochastic | Strength | 0.00% | |
| NR7 | Range Contraction | -1.71% | |
| NR7-2 | Range Contraction | -1.71% | |
| Earnings Movers | Other | -1.71% | |
| Wide Bands | Range Expansion | -1.71% | |
| Overbought Stochastic | Strength | -1.71% |
Free Daily (Stock) Chart Reading
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 06/02/2020
- Sector: Healthcare
- Industry: Drug Manufacturers - Specialty & Generic
Heron Therapeutics, Inc., a specialty pharmaceutical company, develops product candidates using its proprietary Biochronomer polymer-based drug delivery platform. The company's drug delivery platform is designed to improve the therapeutic profile of injectable pharmaceuticals by converting them from products that should be injected once or twice per day to products that need to be injected once every one or two weeks. Its lead product candidate, Sustol, is developed for the prevention of both acute- and delayed-onset chemotherapy-induced nausea and vomiting for patients undergoing emetogenic chemotherapy. The company was formerly known as A.P. Pharma, Inc. and changed its name to Heron Therapeutics, Inc. in January 2014. Heron Therapeutics, Inc. was founded in 1983 and is headquartered in Redwood City, California.
Medicine Health Pharmaceutical Clinical Medicine Oncology Cancer Treatments Chemotherapy Occupational Safety And Health Antineoplastic Drugs Drug Delivery Injectable Pharmaceuticals
Medicine Health Pharmaceutical Clinical Medicine Oncology Cancer Treatments Chemotherapy Occupational Safety And Health Antineoplastic Drugs Drug Delivery Injectable Pharmaceuticals
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 26.81 |
| 52 Week Low | 9.6 |
| Average Volume | 1,010,053 |
| 200-Day Moving Average | 19.10 |
| 50-Day Moving Average | 14.93 |
| 20-Day Moving Average | 16.79 |
| 10-Day Moving Average | 18.37 |
| Average True Range | 0.91 |
| ADX | 32.46 |
| +DI | 33.22 |
| -DI | 13.91 |
| Chandelier Exit (Long, 3 ATRs ) | 16.77 |
| Chandelier Exit (Short, 3 ATRs ) | 16.42 |
| Upper Bollinger Band | 20.18 |
| Lower Bollinger Band | 13.40 |
| Percent B (%b) | 0.74 |
| BandWidth | 40.37 |
| MACD Line | 1.09 |
| MACD Signal Line | 0.96 |
| MACD Histogram | 0.1296 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 19.75 | ||||
| Resistance 3 (R3) | 19.86 | 19.54 | 19.53 | ||
| Resistance 2 (R2) | 19.54 | 19.20 | 19.48 | 19.45 | |
| Resistance 1 (R1) | 18.99 | 19.00 | 18.82 | 18.87 | 19.38 |
| Pivot Point | 18.66 | 18.66 | 18.58 | 18.60 | 18.66 |
| Support 1 (S1) | 18.11 | 18.33 | 17.95 | 17.99 | 17.48 |
| Support 2 (S2) | 17.79 | 18.12 | 17.73 | 17.41 | |
| Support 3 (S3) | 17.23 | 17.79 | 17.33 | ||
| Support 4 (S4) | 17.11 |
